Dong-E-E-Jiao Co Ltd
SZSE:000423
Dong-E-E-Jiao Co Ltd
SZSE:000423
Price:
54.86
CNY
0.15%
Market Closed
Market Cap:
¥35.2B
Relative Value
The Relative Value of one
Dong-E-E-Jiao Co Ltd
stock under the Base Case scenario is
51.27
CNY.
Compared to the current market price of 54.86 CNY,
Dong-E-E-Jiao Co Ltd
is
Overvalued by 7%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Relative Value
Base Case
51.27
CNY
Overvaluation 7%
Multiples Across Competitors
Competitors Multiples
Dong-E-E-Jiao Co Ltd Competitors
Dong-E-E-Jiao Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
|
Dong-E-E-Jiao Co Ltd
SZSE:000423
|
35.3B CNY | 5.5 | 20.8 | 14.9 | 14.9 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
965.7B USD | 14.8 | 46.9 | 31.6 | 33.6 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
594B USD | 6.3 | 22.2 | 15.4 | 18.9 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
292.5B CHF | 4.7 | 31 | 13.1 | 15.2 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
238.2B GBP | 5.5 | 31.6 | 17.4 | 24.6 | |
| CH |
|
Novartis AG
SIX:NOVN
|
242.9B CHF | 5.5 | 22.2 | 13.7 | 17.6 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
303.7B USD | 4.7 | 16.6 | 10.4 | 12.1 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK | 4.3 | 13.1 | 9.6 | 11.3 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
152.2B USD | 2.4 | 19.7 | 7.3 | 9.8 | |
| UK |
|
GlaxoSmithKline PLC
LSE:GSK
|
91B GBP | 2.8 | 15.8 | 8 | 11.3 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
